Guglielmo Gallone

Dr. Guglielmo Gallone

Auto-generated profile, based on publicly available information

Dr. Guglielmo Gallone


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2023 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
GGGuglielmo Gallone
Guglielmo Gallone
MBMatteo Bellettini
Matteo Bellettini
MGMarco Gatti
Marco Gatti
Davide ToreDavide Tore
Davide Tore
FBFrancesco Bruno
Francesco Bruno
Fabrizio D'AscenzoFabrizio D'Ascenzo
Fabrizio D'Ascenzo

1 December 2018 in JACC
Verified
Journal Article
Closed access
GGGuglielmo Gallone
Guglielmo Gallone
LBLuca Baldetti
Luca Baldetti
MPMatteo Pagnesi
Matteo Pagnesi
Azeem LatibAzeem Latib
Azeem Latib
ACAntonio Colombo
Antonio Colombo
FGFrancesco Giannini
Francesco Giannini

1 October 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
FGFrancesco Giannini
Francesco Giannini
LBLuca Baldetti
Luca Baldetti
MKMaayan Konigstein
Maayan Konigstein
LRLiesbeth Rosseel
Liesbeth Rosseel
NRNeil Ruparelia
Neil Ruparelia
SVStefan Verheye
Stefan Verheye

8 December 2020 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Closed access
FBFrancesco Bruno
Francesco Bruno
FDFabrizio D’aScenzo
Fabrizio D’aScenzo
MVMatteo Pio Vaira
Matteo Pio Vaira
EEEdoardo Elia
Edoardo Elia
POPierluigi Omedè
Pierluigi Omedè
GFGaetano Maria De Ferrari
Gaetano Maria De Ferrari
Aims: Permanent pacemaker implantation (PPI) may be required after transcatheter aortic valve implantation (TAVI). Evidence on PPI prediction has largely been gathered from high-risk patients receiving first-generation valve implants. We undertook a meta-analysis of the existing literature to examine the incidence and predictors of PPI after TAVI according to generation of valve, valve type, and surgical risk.Methods and results: We made a systematic literature search for studies with ≥100 patients reporting the incidence and adjusted predictors of PPI after TAVI. Subgroup analyses examined these features according to generation of valve, specific valve type, and surgical risk. We obtained data from 43 studies, encompassing 29 113 patients. Permanent pacemaker implantation rates ranged from 6.7% to 39.2% in individual studies with a pooled incidence of 19% (95% CI 16–21). Independent predictors for PPI were age [odds ratio (OR) 1.05, 95% confidence interval (CI) 1.01–1.09], left bundle branch block (LBBB) (OR 1.45, 95% CI 1.12–1.77), right bundle branch block (RBBB) (OR 4.15, 95% CI 3.23–4.88), implantation depth (OR 1.18, 95% CI 1.11–1.26), and self-expanding valve prosthesis (OR 2.99, 95% CI 1.39–4.59). Among subgroups analysed according to valve type, valve generation and surgical risk, independent predictors were RBBB, self-expanding valve type, first-degree atrioventricular block, and implantation depth.Conclusions: The principle independent predictors for PPI following TAVI are age, RBBB, LBBB, self-expanding valve type, and valve implantation depth. These characteristics should be taken into account in pre-procedural assessment to reduce PPI rates. PROSPERO ID CRD42020164043.

1 September 2019 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
FGFrancesco Giannini
Francesco Giannini
APAnna Palmisano
Anna Palmisano
LBLuca Baldetti
Luca Baldetti
GBGiulia Benedetti
Giulia Benedetti
FPFrancesco Ponticelli
Francesco Ponticelli
AEAntonio Esposito
Antonio Esposito

1 September 2021 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
ODOspedale dell'Angelo
Ospedale dell'Angelo
GGGuglielmo Gallone
Guglielmo Gallone
WKWon-Keun Kim
Won-Keun Kim
JRJoerg Reifart
Joerg Reifart
VVVerena Veulemans
Verena Veulemans
FGFrancesco Giannini
Francesco Giannini
Background: An increased degree of aortic angulation (AA) represents a challenging feature for bioprosthesis positioning. Whether AA has an impact on procedural outcomes of contemporary self-expanding valves remains unsettled. The aim of this study was to evaluate the impact of AA on procedural outcomes of transcatheter aortic valve replacement with contemporary self-expanding valves. Methods: The HORSE (Horizontal Aorta in Transcatheter Self-Expanding Valves) is an international, retrospective registry including 3862 consecutive patients undergoing transcatheter aortic valve replacement with either Evolut R/PRO (n=1959) or ACURATE neo (n=1903) devices. Patients undergoing Evolut R 34 mm implantation were excluded as no comparable prosthesis size for ACURATE neo is available. AA was evaluated with preprocedural computed tomography, and its impact on device success was evaluated. Results: In the overall population, AA did not have any impact upon device success, also when adjusting for in-study outcome predictors (odds ratio for 1° increment, 0.99 [95% CI, 0.98–1.01], P =0.306). However, increased AA was associated with lower device success with use of the Evolut R/PRO valves (odds ratio, 0.97 [95% CI, 0.95–0.99]; P =0.004), but not the ACURATE neo valves (odds ratio, 1.00 [95% CI, 0.98–1.03], P =0.304). The best AA cutoff value predicting device success was 49° (47% of the study cohort). Among patients with AA≥49°, Evolut R/PRO valves were associated with lower device success as compared to the ACURATE neo valve (inverse probability weighting odds ratio, 0.62 [95% CI, 0.46–0.83]; P =0.002). Conclusions: Horizontal aorta, as defined by an AA ≥49°, is a common feature among transcatheter aortic valve replacement candidates and predicts device failure of the Evolut R/PRO valves, but not of the ACURATE neo valve. AA may be an effect modifier of the association between self-expanding valve type and device success.